(Q37867672)

24 August 2017

1 reference

title

Pulmonary veno-occlusive disease: advances in clinical management and treatments (English)

1 reference

24 August 2017

1

1 reference

24 August 2017

3

1 reference

24 August 2017

6

1 reference

24 August 2017

Marc Humbert

5

0 references

Barbara Girerd

series ordinal

2

object named as

Barbara Girerd

1 reference

24 August 2017

Dermot S. O'Callaghan

series ordinal

4

object named as

Dermot O'Callaghan

1 reference

24 August 2017

language of work or name

1 reference

1 April 2011

1 reference

Expert Review of Respiratory Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

5

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

217-29; quiz 230-1

1 reference

Updated clinical classification of pulmonary hypertension.

24 August 2017

cites work

1 reference

Pathologic assessment of vasculopathies in pulmonary hypertension

21 January 2018

1 reference

Pulmonary veno-occlusive disease

21 January 2018

1 reference

Pulmonary Veno-occlusive Disease

21 January 2018

1 reference

Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.

21 January 2018

1 reference

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

Pulmonary veno-occlusive disease: a case series and new observations

21 January 2018

1 reference

Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis

21 January 2018

1 reference

Pulmonary veno-occlusive disease in a HIV-infected intravenous drug abuser.

21 January 2018

1 reference

Risk factors for pulmonary arterial hypertension.

21 January 2018

1 reference

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

21 January 2018

1 reference

Pulmonary hypertension and fenfluramine

21 January 2018

1 reference

Pulmonary veno-occlusive disease after chemotherapy

21 January 2018

1 reference

Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature

21 January 2018

1 reference

Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia

21 January 2018

1 reference

Pulmonary veno-occlusive disease after bone marrow transplantation

21 January 2018

1 reference

Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation.

21 January 2018

1 reference

Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review

21 January 2018

1 reference

Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction

21 January 2018

1 reference

Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries

21 January 2018

1 reference

Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig.

21 January 2018

1 reference

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

21 January 2018

1 reference

Update in pulmonary hypertension 2008.

21 January 2018

1 reference

Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

21 January 2018

1 reference

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

21 January 2018

1 reference

BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

Familial pulmonary veno-occlusive disease: a case report

21 January 2018

1 reference

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

21 January 2018

1 reference

Occult alveolar haemorrhage in pulmonary veno-occlusive disease.

21 January 2018

1 reference

Occult pulmonary haemorrhage in leukaemia

21 January 2018

1 reference

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 January 2018

1 reference

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

Single arterial occlusion to locate resistance in patients with pulmonary hypertension.

21 January 2018

1 reference

Pulmonary capillary pressure in pulmonary hypertension

21 January 2018

1 reference

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.

21 January 2018

1 reference

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

21 January 2018

1 reference

A case of pulmonary veno-occlusive disease and a new bronchoscopic sign

21 January 2018

1 reference

Contraindications and safety of transbronchial lung biopsy via flexible bronchoscopy. A survey of pulmonologists and review of the literature

21 January 2018

1 reference

The pathology of pulmonary veno-occlusive disease.

21 January 2018

1 reference

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

21 January 2018

1 reference

Standard therapies for pulmonary arterial hypertension

21 January 2018

1 reference

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease

21 January 2018

1 reference

Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure

21 January 2018

1 reference

Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease.

21 January 2018

1 reference

Pulmonary venoocclusive disease: case report and review of the literature

21 January 2018

1 reference

One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease

21 January 2018

1 reference

Inflammation in pulmonary arterial hypertension.

21 January 2018

1 reference

Treatment of pulmonary hypertension secondary to connective tissue diseases.

21 January 2018

1 reference

Primary pulmonary hypertension: Current therapy.

21 January 2018

1 reference

Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences

21 January 2018

1 reference

Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis

21 January 2018

1 reference

Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.11.15

1 reference

24 August 2017

1 reference